Koshinski Asset Management Inc. cut its position in Xylem Inc. (NYSE:XYL – Free Report) by 11.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,831 shares of the industrial products company’s stock after selling 1,099 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Xylem were worth $1,141,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of Xylem during the fourth quarter valued at about $198,207,000. Artisan Partners Limited Partnership purchased a new stake in Xylem during the 4th quarter worth approximately $187,207,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main raised its position in shares of Xylem by 1,503.7% in the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,649,926 shares of the industrial products company’s stock valued at $188,685,000 after purchasing an additional 1,547,043 shares in the last quarter. Kodai Capital Management LP purchased a new position in shares of Xylem during the 4th quarter valued at approximately $133,945,000. Finally, Balyasny Asset Management L.P. grew its position in shares of Xylem by 4,769.0% during the fourth quarter. Balyasny Asset Management L.P. now owns 927,390 shares of the industrial products company’s stock worth $106,056,000 after buying an additional 908,343 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In related news, SVP Rodney Aulick sold 21,800 shares of the company’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the sale, the senior vice president now owns 76,287 shares of the company’s stock, valued at $10,604,655.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, SVP Rodney Aulick sold 21,800 shares of the business’s stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the sale, the senior vice president now owns 76,287 shares of the company’s stock, valued at $10,604,655.87. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Geri-Michelle Mcshane sold 2,278 shares of the stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the transaction, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at $490,195.68. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.
Xylem Stock Performance
Xylem (NYSE:XYL – Get Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.84 by $0.06. The company had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2 billion. Xylem had a net margin of 8.34% and a return on equity of 8.95%. Xylem’s revenue was up 40.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.72 earnings per share. On average, research analysts expect that Xylem Inc. will post 4.22 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th were paid a $0.36 dividend. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.44 annualized dividend and a dividend yield of 1.04%. Xylem’s payout ratio is 51.25%.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on XYL. Royal Bank of Canada upped their price target on shares of Xylem from $157.00 to $162.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. Robert W. Baird boosted their price objective on Xylem from $151.00 to $155.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. TD Cowen increased their target price on Xylem from $135.00 to $138.00 and gave the stock a “buy” rating in a report on Thursday, June 6th. Citigroup boosted their price target on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a report on Monday, April 8th. Finally, Mizuho raised their price objective on Xylem from $110.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, May 3rd. Five research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, Xylem presently has an average rating of “Moderate Buy” and an average target price of $142.92.
Read Our Latest Stock Analysis on Xylem
Xylem Company Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Stories
- Five stocks we like better than Xylem
- How to Evaluate a Stock Before BuyingÂ
- Parabolic Rise of This Stock Shows No Signs of Slowing
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Risk Tolerance vs. Risk Appetite: Key Differences
- Using the MarketBeat Dividend Tax Calculator
- Why This Leading Health Stock is a Buy No Matter the Market Move
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.